<DOC>
	<DOCNO>NCT01846312</DOCNO>
	<brief_summary>This study conduct United States America ( USA ) . The aim study assess longitudinal variation immune biomarkers subject risk development type 1 diabetes ( T1D ) .</brief_summary>
	<brief_title>An Observational Study Assess Longitudinal Variation Immune Biomarkers Subjects Risk Development Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Subjects general good health judge investigator Participant test positive equal 99th percentile one three islet antibody ( GAD ( glutamic acid decarboxylase ) , IA2 ( islet antigen2 ) , IAA ( insulin autoantibody ) ) Any chronic disorder ( diabetes enrolment ) severe disease , opinion investigator , might jeopardize subject 's safety compliance protocol Female childbearing potential pregnant , breastfeeding , intend become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>